Arun Sanyal
Appearances
- DateMay 7, 2023It is controversial whether glucagon-like peptide 1 (GLP-1) receptor agonists (RA) are associated with adverse pancreatic, gallbladder or biliary outcomes…
- DateMay 7, 2023Background: Nonalcoholic steatohepatitis (NASH) is a major cause of liver-related morbidity, mortality, and the leading indication for liver transplant in the US. Fibrosis is the best predictor of clinical outcomes in NASH…
- DateMay 7, 2023The clinical course of HBV in individuals with HIV coinfection is marked by accelerated disease progression…
- DateMay 6, 2023BACKGROUND: Chronic cholestatic liver diseases, such as primary sclerosing cholangitis (PSC), often lead to end-stage liver disease requiring liver transplantation. PSC also significantly increases the risk of cholangiocarcinoma (CCA)…
Presenter
Speakers
- DateMay 19, 2024BACKGROUND: Hepatocellular (_25R_)26-Hydroxycholesterol (26HC) and 3β-Hydroxy-5-cholestenoic acid (3βHCA) accumulations due to chronic oxysterol 7α-hydroxylase (CYP7B1) suppression represent a major driving force for the transition from metabolic dysfunction-associated steatotic liver (MASL) to ste…
Presenter
Speakers
Virginia COmmonwealth University
